The Technical Analyst
GreenLight Biosciences [GRNA]
Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
GreenLight Biosciences Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.03% $0.300
America/New_York / 21 jul 2023 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 45.43 mill |
| EPS: | -1.120 |
| P/E: | -0.267 |
| Earnings Date: | Aug 13, 2023 |
| SharesOutstanding: | 151.68 mill |
| Avg Daily Volume: | 0.685 mill |
| RATING 2023-07-21 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/21 | 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | |
| Revenue | n/a | n/a | ||||
| Gr.Profit | n/a | n/a | ||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.267 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.05x |
| Company: PE -0.267 | industry: PE 5.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.289 - 0.311 ( +/- 3.67%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-07-24 | Kodiak Venture Partners Iii Lp | Sell | 9 809 895 | Common Stock, par value $0.0001 per share |
| 2023-05-29 | Kodiak Venture Partners Iii Lp | Sell | 0 | Common Stock |
| 2023-07-24 | Clarke Dennis A. | Buy | 25 510 | Common Stock, par value $0.0001 per share |
| 2023-07-24 | Anderson Eric Senior | Sell | 25 510 | Common Stock, par value $0.0001 per share |
| 2023-07-24 | Cummings Foundation, Inc. | Sell | 1 275 510 | Common Stock, par value $0.0001 per share |
| INSIDER POWER |
|---|
| -93.58 |
| Last 91 transactions |
| Buy: 10 857 483 | Sell: 96 461 941 |
Forecast:
01:40 - $0.224
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.300 (-0.03% ) |
| Volume | 0.143 mill |
| Avg. Vol. | 0.685 mill |
| % of Avg. Vol | 20.91 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For GRNA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
GRNA
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
Latest Press Releases
2023-07-24 09:49:00 - Press Release
Greenlight Announces Completion Of Merger With Fall Line Endurance Fund
Lexington, mass., july 24, 2023 (globe newswire) -- greenlight biosciences holdings, pbc (nasdaq: grna) (“greenlight” or the “company”) today announced the closing of its previously announced merger with sw mergerco, inc. (“merger sub”) and sw parentco, inc. (“parent”), pursuant to which merger sub merged with and into greenlight with greenlight surviving as a wholly-owned subsidiary of parent (the “merger”). following the completion of the merger, shares of greenlight common stock, par value $0.0001 per share, and greenlight warrants ceased trading on the nasdaq global market (the “nasdaq”) before market open on july 24, 2023, and will no longer be listed for trading on the nasdaq...
2023-07-20 08:06:00 - Press Release
Greenlight Biosciences Announces Expiration Of Tender Offer Period For Outstanding Shares
Completion of previously announced merger and going private transaction expected july 20, 2023 completion of previously announced merger and going private transaction expected july 20, 2023
Latest News
2022-12-08 16:27:00 - The Motley Fool
Why Greenlight Biosciences Stock Was in the Red Today
2022-10-12 07:29:00 - Market Watch
GreenLight Biosciences to cut 25% of its workforce as part of ‘realignment' to extend cash runway
GreenLight Biosciences Holdings GRNA, -1.44% said Wednesday that it was laying off 25% of its workforce as part of a “realignment” aimed at saving cash as it shifts its focus to near-term value drivers. The biotechnology company had 312 full-time employees as of March 31.
2022-08-16 07:14:04 - Benzinga
Executives Buy Around $35M Of 4 Penny Stocks: Nextdoor, GreenLight Biosciences And More
The Dow Jones jumped by around 150 points on Monday. Investors, meanwhile, focused on some notable insider trades.
2022-08-04 12:06:19 - The Motley Fool
Why GreenLight Biosciences Stock Is Crushing It Today
